These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8545244)

  • 1. Changes in CNS neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment.
    Stinus L; Allard M; Gold L; Simonnet G
    Peptides; 1995; 16(7):1235-41. PubMed ID: 8545244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats.
    Devillers JP; Boisserie F; Laulin JP; Larcher A; Simonnet G
    Brain Res; 1995 Nov; 700(1-2):173-81. PubMed ID: 8624708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
    Elhabazi K; Trigo JM; Mollereau C; Moulédous L; Zajac JM; Bihel F; Schmitt M; Bourguignon JJ; Meziane H; Petit-demoulière B; Bockel F; Maldonado R; Simonin F
    Br J Pharmacol; 2012 Jan; 165(2):424-35. PubMed ID: 21718302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of neuropeptide FF neurons in the brainstem nucleus tractus solitarius following cardiovascular challenge and opiate withdrawal.
    Jhamandas JH; Harris KH; Petrov T; Yang HY; Jhamandas KH
    J Comp Neurol; 1998 Dec; 402(2):210-21. PubMed ID: 9845244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat.
    Lake JR; Hammond MV; Shaddox RC; Hunsicker LM; Yang HY; Malin DH
    Neurosci Lett; 1991 Oct; 132(1):29-32. PubMed ID: 1787914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs.
    Tan PP; Chen JC; Li JY; Liang KW; Wong CH; Huang EY
    Peptides; 1999; 20(10):1211-7. PubMed ID: 10573293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide FF, a mammalian neuropeptide with multiple functions.
    Panula P; Aarnisalo AA; Wasowicz K
    Prog Neurobiol; 1996; 48(4-5):461-87. PubMed ID: 8804117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subtype-specific neuropeptide FF receptor antagonist attenuates morphine and nicotine withdrawal syndrome in the rat.
    Malin DH; Henceroth MM; Elayoubi J; Campbell JR; Anderson A; Goyarzu P; Izygon J; Madison CA; Ward CP; Burstein ES
    Neurosci Lett; 2018 Sep; 684():98-103. PubMed ID: 29981879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome.
    Malin DH; Lake JR; Smith DA; Jones JA; Morel J; Claunch AE; Stevens PA; Payza K; Ho KK; Liu J
    Drug Alcohol Depend; 1995 Nov; 40(1):37-42. PubMed ID: 8746922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic intracerebroventricular infusion of the antiopioid peptide, Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 (NPFF), downregulates mu opioid binding sites in rat brain.
    Rothman RB; Brady LS; Xu H; Long JB
    Peptides; 1993; 14(6):1271-7. PubMed ID: 8134310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
    Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
    Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analog of neuropeptide FF attenuates morphine tolerance.
    Lake JR; Hebert KM; Payza K; Deshotel KD; Hausam DD; Witherspoon WE; Arcangeli KA; Malin DH
    Neurosci Lett; 1992 Nov; 146(2):203-6. PubMed ID: 1491790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analog of neuropeptide FF attenuates morphine abstinence syndrome.
    Malin DH; Lake JR; Leyva JE; Hammond MV; Rogillio RB; Arcangeli KR; Ludgate K; Moore GM; Payza K
    Peptides; 1991; 12(5):1011-4. PubMed ID: 1800944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-opioid efficacy of neuropeptide FF in morphine-tolerant mice.
    Gelot A; Francés B; Roussin A; Latapie JP; Zajac JM
    Brain Res; 1998 Oct; 808(2):166-73. PubMed ID: 9767158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide FF in the rat spinal cord during carrageenan inflammation.
    Kontinen VK; Aarnisalo AA; Idänpään-Heikkilä JJ; Panula P; Kalso E
    Peptides; 1997; 18(2):287-92. PubMed ID: 9149302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat.
    Gold LH; Stinus L; Inturrisi CE; Koob GF
    Eur J Pharmacol; 1994 Feb; 253(1-2):45-51. PubMed ID: 8013548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain- and morphine-associated transcriptional regulation of neuropeptide FF and the G-protein-coupled NPFF2 receptor gene.
    Nystedt JM; Lemberg K; Lintunen M; Mustonen K; Holma R; Kontinen VK; Kalso E; Panula P
    Neurobiol Dis; 2004 Jun; 16(1):254-62. PubMed ID: 15207282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropeptide FF receptors: structure-activity relationship and effect of morphine.
    Payza K; Akar CA; Yang HY
    J Pharmacol Exp Ther; 1993 Oct; 267(1):88-94. PubMed ID: 8229791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of oxytocin in the neuroadaptation to drugs of abuse.
    Sarnyai Z; Kovács GL
    Psychoneuroendocrinology; 1994; 19(1):85-117. PubMed ID: 9210215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.